Doulatov, Sergei <br/><br/>
Drug discovery for Diamond-Blackfan anemia using reprogrammed hematopoietic progenitors.  [electronic resource] 

 -  Science translational medicine  02 2017 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1946-6242 
<br/><br/><label>Standard No.: </label>10.1126/scitranslmed.aah5645  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Allyl Compounds--pharmacology<br/>Anemia, Diamond-Blackfan--drug therapy<br/>Antigens, CD34--metabolism<br/>Autophagy--drug effects<br/>Autophagy-Related Protein 5--metabolism<br/>Cell Differentiation--drug effects<br/>Cellular Reprogramming<br/>Drug Discovery<br/>Erythroid Cells--drug effects<br/>Erythropoiesis--drug effects<br/>Genetic Complementation Test<br/>Globins--metabolism<br/>Hematopoietic Stem Cell Transplantation<br/>Hematopoietic Stem Cells--drug effects<br/>Humans<br/>Induced Pluripotent Stem Cells--drug effects<br/>Quinazolines--pharmacology